Podocyte-associated talin1 is critical for glomerular filtration barrier maintenance

Journal of Clinical Investigation

Volumn 124, Issue 3, 2014, Pages 1098-1113

  Tian, Xuefei ^a   Kim, Jin Ju ^b   Monkley, Susan M ^c   Gotoh, Nanami ^a   Nandez, Ramiro ^a   Soda, Keita ^a   Inoue, Kazunori ^a   Balkin, Daniel M ^a   Hassan, Hossam ^a   Son, Sung Hyun ^a   Lee, Yashang ^a   Moeckel, Gilbert ^a   Calderwood, David A ^a   Holzman, Lawrence B ^d   Critchley, David R ^c   Zent, Roy ^e   Reiser, Jochen ^f   Ishibe, Shuta ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALPAIN; CALPASTATIN; CD8 ANTIGEN; COLLAGEN TYPE 1; CREATININE; CYTOSKELETON PROTEIN; FIBRONECTIN; NEPHRIN; PAXILLIN; TALIN; TALIN 1; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SPREADING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; FIBROSING ALVEOLITIS; FOCAL ADHESION; FOCAL GLOMERULOSCLEROSIS; GLOMERULAR FILTRATION BARRIER; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; GLOMERULUS FILTRATION; HUMAN; HUMAN TISSUE; INTERNALIZATION; KIDNEY FAILURE; KIDNEY INJURY; MOUSE; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DEPLETION; PROTEINURIA; STRESS FIBER; URINALYSIS;

ACTIN CYTOSKELETON; ANIMALS; ANTIGENS, CD29; CALPAIN; CELL ADHESION; CELLS, CULTURED; FOCAL ADHESIONS; GLOMERULAR FILTRATION BARRIER; HUMANS; MICE; MICE, KNOCKOUT; NEPHROTIC SYNDROME; PODOCYTES; PROTEINURIA; PROTEOLYSIS; RENAL INSUFFICIENCY; TALIN;

EID: 84896795311     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI69778     Document Type: Article

References (69)

1. Sachs N, Sonnenberg A. Cell-matrix adhesion of podocytes in physiology and disease. Nat Rev Nephrol. 2013;9(4):200-210.
2. Pozzi A, et al. β1 Integrin expression by podocytes is required to maintain glomerular structural integrity. Dev Biol. 2008;316(2):288-301.
3. Kreidberg JA, et al. α3β1 Integrin has a crucial role in kidney and lung organogenesis. Development. 1996;122(11):3537-3547.
4. Sachs N, et al. Kidney failure in mice lacking the tetraspanin CD151. J Cell Biol. 2006;175(1):33-39.
5. Jarad G, Cunningham J, Shaw AS, Miner JH. Proteinuria precedes podocyte abnormalities in Lamb2-/-mice, implicating the glomerular basement membrane as an albumin barrier. J Clin Invest. 2006; 116(8):2272-2279.
6. Wei C, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011;17(8):952-960.
7. Bouaouina M, Harburger DS, Calderwood DA. Talin and signaling through integrins. Methods Mol Biol. 2012;757:325-347.
8. Dai C, et al. Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol. 2006; 17(8):2164-2175.
9. El-Aouni C, et al. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis. J Am Soc Nephrol. 2006; 17(5):1334-1344.
10. Kanasaki K, et al. Integrin beta1-mediated matrix assembly and signaling are critical for the normal development and function of the kidney glomerulus. Dev Biol. 2008;313(2):584-593.
11. Debrand E, et al. Talin 2 is a large and complex gene encoding multiple transcripts and protein isoforms. FEBS J. 2009;276(6):1610-1628.
12. Critchley DR. Biochemical and structural properties of the integrin-associated cytoskeletal protein talin. Annu Rev Biophys. 2009;38:235-254.
13. Garcia-Alvarez B, et al. Structural determinants of integrin recognition by talin. Mol Cell. 2003; 11(1):49-58.
14. Tadokoro S, et al. Talin binding to integrin β tails: a final common step in integrin activation. Science. 2003;302(5642):103-106.
15. Di Paolo G, et al. Recruitment and regulation of phosphatidylinositol phosphate kinase type 1 γ by the FERM domain of talin. Nature. 2002; 420(6911):85-89.
16. Barsukov IL, et al. Phosphatidylinositol phosphate kinase type 1γ and β1-integrin cytoplasmic domain bind to the same region in the talin FERM domain. J Biol Chem. 2003;278(33):31202-31209.
17. Lee SY, Voronov S, Letinic K, Nairn AC, Di Paolo G, De Camilli P. Regulation of the interaction between PIPKIγ and talin by proline-directed protein kinases. J Cell Biol. 2005;168(5):789-799.
18. Goult BT, et al. Structure of a double ubiquitin-like domain in the talin head: a role in integrin activation. EMBO J. 2010;29(6):1069-1080.
19. Gingras AR, et al. Structural determinants of integrin binding to the talin rod. J Biol Chem. 2009; 284(13):8866-8876.
20. Gingras AR, et al. Central region of talin has a unique fold that binds vinculin and actin. J Biol Chem. 2010;285(38):29577-29587.
21. Gingras AR, et al. Structural and dynamic characterization of a vinculin binding site in the talin rod. Biochemistry. 2006;45(6):1805-1817.
22. Zhang X, Jiang G, Cai Y, Monkley SJ, Critchley DR, Sheetz MP. Talin depletion reveals independence of initial cell spreading from integrin activation and traction. Nat Cell Biol. 2008;10(9):1062-1068.
23. Franco SJ, et al. Calpain-mediated proteolysis of talin regulates adhesion dynamics. Nat Cell Biol. 2004;6(10):977-983.
24. Nicolaou N, et al. Gain of glycosylation in integrin α3 causes lung disease and nephrotic syndrome. J Clin Invest. 2012;122(12):4375-4387.
25. Has C, et al. Integrin α3 mutations with kidney, lung, and skin disease. N Engl J Med. 2012; 366(16):1508-1514.
26. Hasselbacher K, et al. Recessive missense mutations in LAMB2 expand the clinical spectrum of LAMB2-associated disorders. Kidney Int. 2006;70(6):1008-1012.
27. Chen YM, Kikkawa Y, Miner JH. A missense LAMB2 mutation causes congenital nephrotic syndrome by impairing laminin secretion. J Am Soc Nephrol. 2011;22(5):849-858.
28. Yao J, et al. α-Actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein. PLoS Biol. 2004;2(6):e167.
29. Brown EJ, et al. Mutations in the formin gene INF2 cause focal segmental glomerulosclerosis. Nat Genet. 2010;42(1):72-76.
30. Mele C, et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med. 2011;365(4):295-306.
31. Monkley SJ, et al. Disruption of the talin gene arrests mouse development at the gastrulation stage. Dev Dyn. 2000;219(4):560-574.
32. Moeller MJ, Sanden SK, Soofi A, Wiggins RC, Holzman LB. Podocyte-specific expression of cre recombinase in transgenic mice. Genesis. 2003;35(1):39-42.
33. Debrand E, et al. Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. Biochem Biophys Res Commun. 2012;426(2):190-195.
34. Calderwood DA, Zent R, Grant R, Rees DJ, Hynes RO, Ginsberg MH. The Talin head domain binds to integrin β subunit cytoplasmic tails and regulates integrin activation. J Biol Chem. 1999; 274(40):28071-28074.
35. Czuchra A, Meyer H, Legate KR, Brakebusch C, Fassler R. Genetic analysis of β1 integrin "activation motifs" in mice. J Cell Biol. 2006;174(6):889-899.
36. Wang P, Ballestrem C, Streuli CH. The C terminus of talin links integrins to cell cycle progression. J Cell Biol. 2011;195(3):499-513.
37. Morgan JR, et al. A role for talin in presynaptic function. J Cell Biol. 2004;167(1):43-50.
38. Soda K, et al. Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. J Clin Invest. 2012;122(12):4401-4411.
39. Burkel BM, von Dassow G, Bement WM. Versatile fluorescent probes for actin filaments based on the actin-binding domain of utrophin. Cell Motil Cytoskeleton. 2007;64(11):822-832.
40. George B, et al. Crk1/2-dependent signaling is necessary for podocyte foot process spreading in mouse models of glomerular disease. J Clin Invest. 2012; 122(2):674-692.
41. Mundel P, Reiser J. Proteinuria: an enzymatic disease of the podocyte? Kidney Int. 2010;77(7):571-580.
42. Bate N, et al. Talin contains a C-terminal calpain2 cleavage site important in focal adhesion dynamics. PLoS One. 2012;7(4):e34461.
43. Peltier J, et al. Calpain activation and secretion promote glomerular injury in experimental glomerulonephritis: evidence from calpastatin-transgenic mice. J Am Soc Nephrol. 2006;17(12):3415-3423.
44. Chan KT, Bennin DA, Huttenlocher A. Regulation of adhesion dynamics by calpain-mediated proteolysis of focal adhesion kinase (FAK). J Biol Chem. 2010;285(15):11418-11426.
45. Serrano K, Devine DV. Vinculin is proteolyzed by calpain during platelet aggregation: 95 kDa cleavage fragment associates with the platelet cytoskeleton. Cell Motil Cytoskeleton. 2004;58(4):242-252.
46. Kelly BL, Ferreira A. β-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J Biol Chem. 2006;281(38):28079-28089.
47. Kwak HI, et al. Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation. Angiogenesis. 2012;15(2):287-303.
48. Cortesio CL, Boateng LR, Piazza TM, Bennin DA, Huttenlocher A. Calpain-mediated proteolysis of paxillin negatively regulates focal adhesion dynamics and cell migration. J Biol Chem. 2011;286(12):9998-10006.
49. Lade A, Ranganathan S, Luo J, Monga SP. Calpain induces N-terminal truncation of β-catenin in normal murine liver development: diagnostic implications in hepatoblastomas. J Biol Chem. 2012; 287(27):22789-22798.
50. Calderwood DA, Campbell ID, Critchley DR. Talins and kindlins: partners in integrin-mediated adhesion. Nat Rev Mol Cell Biol. 2013;14(8):503-517.
51. Sachs N, et al. Blood pressure influences end-stage renal disease of Cd151 knockout mice. J Clin Invest. 2012;122(1):348-358.
52. Ma H, et al. Inhibition of podocyte FAK protects against proteinuria and foot process effacement. J Am Soc Nephrol. 2010;21(7):1145-1156.
53. Chiluiza D, Krishna S, Schumacher VA, Schlöndorff J. Gain-of-function mutations in transient receptor potential C6 (TRPC6) activate extracellular-signal-regulated kinases Erk1/2. J Biol Chem. 2013;288(25):18407- 18420.
54. Yu CC, et al. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med. 2013;369(25):2416-2423.
55. Qu H, et al. Kindlin-2 regulates podocyte adhesion and fibronectin matrix deposition through interactions with phosphoinositides and integrins. J Cell Sci. 2011;124(pt 6):879-891.
56. Praekelt U, et al. New isoform-specific monoclonal antibodies reveal different sub-cellular localisations for talin1 and talin2. Eur J Cell Biol. 2012; 91(3):180-191.
57. Durocher Y, Perret S, Kamen A. High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 2002; 30(2):E9.
58. Harita Y, et al. Phosphorylation of nephrin triggers Ca2+ signaling by recruitment and activation of phospholipase Cγ1. J Biol Chem. 2009;284(13):8951-8962.
59. Cong R, Li Y, Biemesderfer D. A disintegrin and metalloprotease 10 activity sheds the ectodomain of the amyloid precursor-like protein 2 and regulates protein expression in proximal tubule cells. Am J Physiol Cell Physiol. 2011;300(6):C1366-C1374.
60. Bouaouina M, Lad Y, Calderwood DA. The N-terminal domains of talin cooperate with the phosphotyrosine binding-like domain to activate β1 and β3 integrins. J Biol Chem. 2008;283(10):6118-6125.
61. Simonson WT, Franco SJ, Huttenlocher A. Talin1 regulates TCR-mediated LFA-1 function. J Immunol. 2006;177(11):7707-7714.
62. Petrich BG, et al. Talin is required for integrin-mediated platelet function in hemostasis and thrombosis. J Exp Med. 2007;204(13):3103-3111.
63. Nieswandt B, et al. Loss of talin1 in platelets abrogates integrin activation, platelet aggregation, and thrombus formation in vitro and in vivo. J Exp Med. 2007;204(13):3113-3118.
64. Chen J, Chen MX, Fogo AB, Harris RC, Chen JK. mVps34 deletion in podocytes causes glomerulosclerosis by disrupting intracellular vesicle trafficking. J Am Soc Nephrol. 2013;24(2):198-207.
65. Ma W, et al. Calpain mediates pulmonary vascular remodeling in rodent models of pulmonary hypertension, and its inhibition attenuates pathologic features of disease. J Clin Invest. 2011;121(11):4548-4566.
66. Uceyler N, Biko L, Sommer C. MDL-28170 has no analgesic effect on CCI induced neuropathic pain in mice. Molecules. 2010;15(5):3038-3047.
67. Verderame M, Alcorta D, Egnor M, Smith K, Pollack R. Cytoskeletal F-actin patterns quantitated with fluorescein isothiocyanate-phalloidin in normal and transformed cells. Proc Natl Acad Sci U S A. 1980;77(11):6624-6628.
68. Boguslavsky S, et al. p120 catenin regulates lamellipodial dynamics and cell adhesion in cooperation with cortactin. Proc Natl Acad Sci U S A. 2007; 104(26):10882-10887.
69. Perera RM, Zoncu R, Lucast L, De Camilli P, Toomre D. Two synaptojanin 1 isoforms are recruited to clathrin-coated pits at different stages. Proc Natl Acad Sci U S A. 2006;103(51):19332-19337.